Fundraising Fox

Eric Easom

Founder

Co-Founder, President & CEO at AN2 Therapeutics

Menlo Park, California, United States

FoundedAN2 Therapeutics

Find your path to Eric

97 people in our graph share verified history with Eric β€” schools, employers, funds. One of them is your warm intro.

Kabeer AzizunlockedEric: together at AN2 Therapeutics (2019–2026)
Γ—5Eric: together at Eli Lilly & Co.
Eric: together at Indiana University - Kelley School of Business
Eric: together at Drugs for Neglected Diseases initiative (DNDi)

About

Eric Easom is CEO and Co-Founder of AN2 Therapeutics, a biotechnology company focused on infectious diseases. He also serves as a Board Member of the Drugs for Neglected Diseases initiative (DNDi).

Co-Founder, President & CEO at AN2 Therapeutics

Intro paths

β†’

In turn, Eric can intro founders to AN2 Therapeutics's investors below.

AN2 Therapeutics's investors Β· 7

Adjuvant CapitalNew York Β· $10M – $25M checks Β· since 2026BioRock VenturesSan Francisco Β· since 2026Biotechnology Value FundSan FranciscoFlucas VenturesJupiter Β· $100K – $5M checks Β· since 2026Hatteras Venture PartnersResearch Triangle Β· $500K – $4M checks Β· since 2026Mountain Group CapitalNashville Β· since 2026RA CapitalBoston Β· since 2026

Co-founders at AN2 Therapeutics

JS
Joseph S. ZakrzewskiCo-Founder & Director
GH
George H. TalbotCo-Founder & Senior Clinical Advisor
MR
Michael R.K. (Dickon) AlleyCo-Founder, SVP Research Fellow, Head of Biology

Experience

  1. Drugs for Neglected Diseases initiative (DNDi)Board Membercurrent2026 β€” presentGeneva, Switzerland
  2. AN2 Therapeutics, Inc.CEO & Co-Foundercurrent2017 β€” presentMenlo Park, CA
  3. Resilient Biotics, Inc.Director, Board of Directorscurrent2019 β€” presentDurham, NC
  4. Chagas Disease FoundationMember Board Of Directorscurrent2018 β€” presentAthens, GA USA
  5. Anacor PharmaceuticalsVice President, Neglected Diseases2009 β€” 2017Palo Alto, CA
  6. Infectious Disease Research InstituteMember Board of Directors2007 β€” 2014Greater Seattle Area
  7. Infectious Disease Research InstituteChair Board of Directors2010 β€” 2013Seattle, WA
  8. InteKrin Therapeutics, Inc.Sr. Director, Business Development and Marketing2007 β€” 2009
  9. MedImmuneDirector of Marketing2006 β€” 2007
  10. McKesson Medical SurgicalDirector, Pharmaceutical Division2005 β€” 2006
  11. Hope PharmaceuicalsFounder and CEO2003 β€” 2005
  12. Eli Lilly & Co.US Brand Manager, Endcrine Business Unit and Humatrope1990 β€” 2003
  13. Eli Lilly & Co.Corporate Business Development1997 β€” 2000
  14. Eli Lilly & Co.Finance1995 β€” 1997
  15. Eli Lilly & Co.Engineer, Manufacturing1990 β€” 1994

Skills & more

Infectious Disease R&D1Biotech R&D Leadership2Non-Dilutive FundraisingBiotechnology37Biochemistry5Business Development20Biotech BOD

From Eric's professional profile.

Frequently asked questions

Who is Eric Easom?
Eric Easom is CEO and Co-Founder of AN2 Therapeutics, a biotechnology company focused on infectious diseases. He also serves as a Board Member of the Drugs for Neglected Diseases initiative (DNDi).
Where does Eric Easom work?
Eric Easom is Co-Founder, President & CEO of AN2 Therapeutics.
What companies did Eric Easom found?
Eric Easom founded AN2 Therapeutics.
Where did Eric Easom go to school?
Eric Easom studied at Indiana University - Kelley School of Business (MBA, Marketing and Finance); University of Louisville (Masters, Electrical Engineering); University of Louisville (BS, Electrical Engineering).

Founder mafias

Indiana University - Kelley School of Business mafia42

Also came through, then founded or led a company.

Scott D. DorseyBachelor's DegreeFounded High Alpha Capital +2Michael RussellBusinessFounded Paintzen +2Griffin MorrisMastersFounded Spatial +1George FangBachelor's degreeFounded Meridian +1Bradley BosticBachelor of ScienceFounded Hc1 +1Daniel CaridiBachelor of Science - BSFounded Kibu +1

+ 35 more

University of Louisville mafia22

Also came through, then founded or led a company.

Buddy BockwegBSFounded Vsimple +1Jermaine WatkinsComputer and Information SystemsFounded WeatherCheckChris ThompsonMaster of ScienceFounded Micrographia BioAdam FishMBAFounded DittoKollan HouseMechanical EngineeringFounded MetaDAOJon MattinglyBachelor of Science (BS)Founded Kodable

+ 15 more

Same school

Also attended Indiana University - Kelley School of Business206

Scott D. DorseyInvestor at High AlphaJoe HaraVice President at Marlin Equity PartnersJack AleksanyanDirector at Marlin Equity PartnersDoug SillsPartner at Anthem Venture Management, LlcDanisha PasayaAnalyst, M&A Advisory at eGateway CapitalAaron DonenbergPortfolio Finance Associate at Energize Ventures

+ 200 more

Also attended University of Louisville39

Tomi AsantiManaging Partner, Real Estate at Innovestor VenturesCandice RezvanianChief Operating Officer at DPI CapitalEmily SnyderPrincipal at Borealis VenturesMike BiddlePartner at Evok InnovationsBillie Jo NutterInvestor at HCAP PartnersMarjolaine MandagotImpact & ESG Manager at Oryx Impact

+ 33 more

Shared employers

Also worked at Drugs for Neglected Diseases initiative (DNDi)1

Ben PerryInvestor at Medicxi

Also worked at AN2 Therapeutics, Inc.4

Kabeer AzizCo-Founder and Partner at Adjuvant CapitalLucy O. DayChief Financial Officer at AN2 TherapeuticsJosh EizenChief Legal Officer and Chief Operating Officer at AN2 TherapeuticsCameron TrenorChief Medical Officer at AN2 Therapeutics

Also worked at InteKrin Therapeutics, Inc.1

Denny LanfearFounder at Coherus Biosciences

Also worked at MedImmune19

Damian Crowtherex-AstraZeneca at PICUS CAPITALArthur SuckowInvestor at 82VSEd MathersPartner at New Enterprise Associates (NEA)Celia HartGeneral Partner at Supernova InvestKevin TyanInvestor at VenrockJennifer ButlerEntrepreneur-in-Residence at BioHealth Innovation, Inc.

+ 13 more